Industry Research Reports
Global Stem Cell Therapy Market Research Report 2025
Industry: Medical Care
Published Date: 2025-09-08
Pages: 99 Pages
Report ld: 3470244
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Stem Cell Therapy Market Size(US$)
CAGR 2025-2031
19.7%
Market Size,2031
USD 2,373
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 807 million
Market Forecast in 2031(Value)
US$ 2,373 million
CAGR
19.7%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Stem Cell Therapy was valued at US$ 685 million in the year 2024 and is projected to reach a revised size of US$ 2373 million by 2031, growing at a CAGR of 19.7% during the forecast period.
Stem cell therapy refers to the use of stem cells to treat or prevent a disease or condition. These cells can differentiate into various specialized cell types, offering potential for regenerating damaged tissues, modulating immune responses, and restoring normal function in affected organs. Downstream applications include treatment for neurodegenerative diseases, cardiovascular disorders, autoimmune conditions, orthopedic injuries, and certain cancers.
The global stem cell therapy market has been gaining momentum due to increasing demand for regenerative medicine and technological advancements in cell-based research. Governments and private sectors are actively investing in clinical trials, research infrastructure, and commercialization strategies. There is a rising incidence of chronic and degenerative diseases, such as Parkinson’s disease, type 1 diabetes, and heart failure, which are driving the adoption of stem cell-based treatments. Moreover, increasing awareness among patients and healthcare professionals about the potential of stem cell therapy is accelerating clinical adoption. Regulatory frameworks are gradually evolving to accommodate the unique aspects of stem cell research, though regional disparities in regulation and ethical concerns still pose challenges. Academic institutions, biotechnology companies, and hospitals are collaborating to translate laboratory research into clinical applications. With continued innovation, the market is expected to expand into personalized medicine, particularly with the integration of gene editing technologies and induced pluripotent stem cells (iPSCs).
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy.
The Stem Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
By Company
- Medipost
- Theracell Advanced Biotechnology
- Nature Cell
- Stempeutics
- Regeneus
- Bluebird bio, Inc
- NIPRO
- Kyowa Kirin
- CorestemChemon Inc.
- ANTEROGEN.CO., LTD.
- Holostem
- NuVasive
- JCR Pharmaceutical
- Pharmicell
- Medi-post
- Anterogen
- Takeda (TiGenix)
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Allogeneic Stem Cell Therapies
- Autologous Stem Cell Therapies
Segment by Application
- Neurodegenerative Diseases
- Cardiovascular Disorders
- Autoimmune Conditions
- Orthopedic Injuries
- Cancer
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Allogeneic Stem Cell Therapies
1.2.3 Autologous Stem Cell Therapies
1.3 Market by Application
1.3.1 Global Stem Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neurodegenerative Diseases
1.3.3 Cardiovascular Disorders
1.3.4 Autoimmune Conditions
1.3.5 Orthopedic Injuries
1.3.6 Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy Market Perspective (2020-2031)
2.2 Global Stem Cell Therapy Growth Trends by Region
2.2.1 Global Stem Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Stem Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Stem Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Stem Cell Therapy Market Dynamics
2.3.1 Stem Cell Therapy Industry Trends
2.3.2 Stem Cell Therapy Market Drivers
2.3.3 Stem Cell Therapy Market Challenges
2.3.4 Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy Players by Revenue
3.1.1 Global Top Stem Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Stem Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top Stem Cell Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Stem Cell Therapy Revenue
3.4 Global Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy Revenue in 2024
3.5 Global Key Players of Stem Cell Therapy Head office and Area Served
3.6 Global Key Players of Stem Cell Therapy, Product and Application
3.7 Global Key Players of Stem Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Therapy Breakdown Data by Type
4.1 Global Stem Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Stem Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Stem Cell Therapy Breakdown Data by Application
5.1 Global Stem Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Stem Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Stem Cell Therapy Market Size (2020-2031)
6.2 North America Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Stem Cell Therapy Market Size by Country (2020-2025)
6.4 North America Stem Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Therapy Market Size (2020-2031)
7.2 Europe Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Stem Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Stem Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Stem Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Stem Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Stem Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Stem Cell Therapy Market Size (2020-2031)
9.2 Latin America Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Stem Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Stem Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Stem Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Stem Cell Therapy Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medipost
11.1.1 Medipost Company Details
11.1.2 Medipost Business Overview
11.1.3 Medipost Stem Cell Therapy Introduction
11.1.4 Medipost Revenue in Stem Cell Therapy Business (2020-2025)
11.1.5 Medipost Recent Development
11.2 Theracell Advanced Biotechnology
11.2.1 Theracell Advanced Biotechnology Company Details
11.2.2 Theracell Advanced Biotechnology Business Overview
11.2.3 Theracell Advanced Biotechnology Stem Cell Therapy Introduction
11.2.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy Business (2020-2025)
11.2.5 Theracell Advanced Biotechnology Recent Development
11.3 Nature Cell
11.3.1 Nature Cell Company Details
11.3.2 Nature Cell Business Overview
11.3.3 Nature Cell Stem Cell Therapy Introduction
11.3.4 Nature Cell Revenue in Stem Cell Therapy Business (2020-2025)
11.3.5 Nature Cell Recent Development
11.4 Stempeutics
11.4.1 Stempeutics Company Details
11.4.2 Stempeutics Business Overview
11.4.3 Stempeutics Stem Cell Therapy Introduction
11.4.4 Stempeutics Revenue in Stem Cell Therapy Business (2020-2025)
11.4.5 Stempeutics Recent Development
11.5 Regeneus
11.5.1 Regeneus Company Details
11.5.2 Regeneus Business Overview
11.5.3 Regeneus Stem Cell Therapy Introduction
11.5.4 Regeneus Revenue in Stem Cell Therapy Business (2020-2025)
11.5.5 Regeneus Recent Development
11.6 Bluebird bio, Inc
11.6.1 Bluebird bio, Inc Company Details
11.6.2 Bluebird bio, Inc Business Overview
11.6.3 Bluebird bio, Inc Stem Cell Therapy Introduction
11.6.4 Bluebird bio, Inc Revenue in Stem Cell Therapy Business (2020-2025)
11.6.5 Bluebird bio, Inc Recent Development
11.7 NIPRO
11.7.1 NIPRO Company Details
11.7.2 NIPRO Business Overview
11.7.3 NIPRO Stem Cell Therapy Introduction
11.7.4 NIPRO Revenue in Stem Cell Therapy Business (2020-2025)
11.7.5 NIPRO Recent Development
11.8 Kyowa Kirin
11.8.1 Kyowa Kirin Company Details
11.8.2 Kyowa Kirin Business Overview
11.8.3 Kyowa Kirin Stem Cell Therapy Introduction
11.8.4 Kyowa Kirin Revenue in Stem Cell Therapy Business (2020-2025)
11.8.5 Kyowa Kirin Recent Development
11.9 CorestemChemon Inc.
11.9.1 CorestemChemon Inc. Company Details
11.9.2 CorestemChemon Inc. Business Overview
11.9.3 CorestemChemon Inc. Stem Cell Therapy Introduction
11.9.4 CorestemChemon Inc. Revenue in Stem Cell Therapy Business (2020-2025)
11.9.5 CorestemChemon Inc. Recent Development
11.10 ANTEROGEN.CO., LTD.
11.10.1 ANTEROGEN.CO., LTD. Company Details
11.10.2 ANTEROGEN.CO., LTD. Business Overview
11.10.3 ANTEROGEN.CO., LTD. Stem Cell Therapy Introduction
11.10.4 ANTEROGEN.CO., LTD. Revenue in Stem Cell Therapy Business (2020-2025)
11.10.5 ANTEROGEN.CO., LTD. Recent Development
11.11 Holostem
11.11.1 Holostem Company Details
11.11.2 Holostem Business Overview
11.11.3 Holostem Stem Cell Therapy Introduction
11.11.4 Holostem Revenue in Stem Cell Therapy Business (2020-2025)
11.11.5 Holostem Recent Development
11.12 NuVasive
11.12.1 NuVasive Company Details
11.12.2 NuVasive Business Overview
11.12.3 NuVasive Stem Cell Therapy Introduction
11.12.4 NuVasive Revenue in Stem Cell Therapy Business (2020-2025)
11.12.5 NuVasive Recent Development
11.13 JCR Pharmaceutical
11.13.1 JCR Pharmaceutical Company Details
11.13.2 JCR Pharmaceutical Business Overview
11.13.3 JCR Pharmaceutical Stem Cell Therapy Introduction
11.13.4 JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2020-2025)
11.13.5 JCR Pharmaceutical Recent Development
11.14 Pharmicell
11.14.1 Pharmicell Company Details
11.14.2 Pharmicell Business Overview
11.14.3 Pharmicell Stem Cell Therapy Introduction
11.14.4 Pharmicell Revenue in Stem Cell Therapy Business (2020-2025)
11.14.5 Pharmicell Recent Development
11.15 Medi-post
11.15.1 Medi-post Company Details
11.15.2 Medi-post Business Overview
11.15.3 Medi-post Stem Cell Therapy Introduction
11.15.4 Medi-post Revenue in Stem Cell Therapy Business (2020-2025)
11.15.5 Medi-post Recent Development
11.16 Anterogen
11.16.1 Anterogen Company Details
11.16.2 Anterogen Business Overview
11.16.3 Anterogen Stem Cell Therapy Introduction
11.16.4 Anterogen Revenue in Stem Cell Therapy Business (2020-2025)
11.16.5 Anterogen Recent Development
11.17 Takeda (TiGenix)
11.17.1 Takeda (TiGenix) Company Details
11.17.2 Takeda (TiGenix) Business Overview
11.17.3 Takeda (TiGenix) Stem Cell Therapy Introduction
11.17.4 Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2020-2025)
11.17.5 Takeda (TiGenix) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Allogeneic Stem Cell Therapies
Table 3. Key Players of Autologous Stem Cell Therapies
Table 4. Global Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Stem Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Stem Cell Therapy Market Share by Region (2020-2025)
Table 8. Global Stem Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Stem Cell Therapy Market Share by Region (2026-2031)
Table 10. Stem Cell Therapy Market Trends
Table 11. Stem Cell Therapy Market Drivers
Table 12. Stem Cell Therapy Market Challenges
Table 13. Stem Cell Therapy Market Restraints
Table 14. Global Stem Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Stem Cell Therapy Market Share by Players (2020-2025)
Table 16. Global Top Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy as of 2024)
Table 17. Ranking of Global Top Stem Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Stem Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Stem Cell Therapy, Product and Application
Table 21. Global Key Players of Stem Cell Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Stem Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Stem Cell Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Stem Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Stem Cell Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Stem Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Medipost Company Details
Table 47. Medipost Business Overview
Table 48. Medipost Stem Cell Therapy Product
Table 49. Medipost Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 50. Medipost Recent Development
Table 51. Theracell Advanced Biotechnology Company Details
Table 52. Theracell Advanced Biotechnology Business Overview
Table 53. Theracell Advanced Biotechnology Stem Cell Therapy Product
Table 54. Theracell Advanced Biotechnology Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. Theracell Advanced Biotechnology Recent Development
Table 56. Nature Cell Company Details
Table 57. Nature Cell Business Overview
Table 58. Nature Cell Stem Cell Therapy Product
Table 59. Nature Cell Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. Nature Cell Recent Development
Table 61. Stempeutics Company Details
Table 62. Stempeutics Business Overview
Table 63. Stempeutics Stem Cell Therapy Product
Table 64. Stempeutics Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. Stempeutics Recent Development
Table 66. Regeneus Company Details
Table 67. Regeneus Business Overview
Table 68. Regeneus Stem Cell Therapy Product
Table 69. Regeneus Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. Regeneus Recent Development
Table 71. Bluebird bio, Inc Company Details
Table 72. Bluebird bio, Inc Business Overview
Table 73. Bluebird bio, Inc Stem Cell Therapy Product
Table 74. Bluebird bio, Inc Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. Bluebird bio, Inc Recent Development
Table 76. NIPRO Company Details
Table 77. NIPRO Business Overview
Table 78. NIPRO Stem Cell Therapy Product
Table 79. NIPRO Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 80. NIPRO Recent Development
Table 81. Kyowa Kirin Company Details
Table 82. Kyowa Kirin Business Overview
Table 83. Kyowa Kirin Stem Cell Therapy Product
Table 84. Kyowa Kirin Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 85. Kyowa Kirin Recent Development
Table 86. CorestemChemon Inc. Company Details
Table 87. CorestemChemon Inc. Business Overview
Table 88. CorestemChemon Inc. Stem Cell Therapy Product
Table 89. CorestemChemon Inc. Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 90. CorestemChemon Inc. Recent Development
Table 91. ANTEROGEN.CO., LTD. Company Details
Table 92. ANTEROGEN.CO., LTD. Business Overview
Table 93. ANTEROGEN.CO., LTD. Stem Cell Therapy Product
Table 94. ANTEROGEN.CO., LTD. Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 95. ANTEROGEN.CO., LTD. Recent Development
Table 96. Holostem Company Details
Table 97. Holostem Business Overview
Table 98. Holostem Stem Cell Therapy Product
Table 99. Holostem Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 100. Holostem Recent Development
Table 101. NuVasive Company Details
Table 102. NuVasive Business Overview
Table 103. NuVasive Stem Cell Therapy Product
Table 104. NuVasive Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 105. NuVasive Recent Development
Table 106. JCR Pharmaceutical Company Details
Table 107. JCR Pharmaceutical Business Overview
Table 108. JCR Pharmaceutical Stem Cell Therapy Product
Table 109. JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 110. JCR Pharmaceutical Recent Development
Table 111. Pharmicell Company Details
Table 112. Pharmicell Business Overview
Table 113. Pharmicell Stem Cell Therapy Product
Table 114. Pharmicell Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 115. Pharmicell Recent Development
Table 116. Medi-post Company Details
Table 117. Medi-post Business Overview
Table 118. Medi-post Stem Cell Therapy Product
Table 119. Medi-post Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 120. Medi-post Recent Development
Table 121. Anterogen Company Details
Table 122. Anterogen Business Overview
Table 123. Anterogen Stem Cell Therapy Product
Table 124. Anterogen Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 125. Anterogen Recent Development
Table 126. Takeda (TiGenix) Company Details
Table 127. Takeda (TiGenix) Business Overview
Table 128. Takeda (TiGenix) Stem Cell Therapy Product
Table 129. Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 130. Takeda (TiGenix) Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. Stem Cell Therapy Picture
Figure 2. Global Stem Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Stem Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. Allogeneic Stem Cell Therapies Features
Figure 5. Autologous Stem Cell Therapies Features
Figure 6. Global Stem Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Stem Cell Therapy Market Share by Application: 2024 VS 2031
Figure 8. Neurodegenerative Diseases Case Studies
Figure 9. Cardiovascular Disorders Case Studies
Figure 10. Autoimmune Conditions Case Studies
Figure 11. Orthopedic Injuries Case Studies
Figure 12. Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Stem Cell Therapy Report Years Considered
Figure 15. Global Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Stem Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Stem Cell Therapy Market Share by Region: 2024 VS 2031
Figure 18. Global Stem Cell Therapy Market Share by Players in 2024
Figure 19. Global Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Stem Cell Therapy Revenue in 2024
Figure 21. North America Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Stem Cell Therapy Market Share by Country (2020-2031)
Figure 23. United States Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Stem Cell Therapy Market Share by Country (2020-2031)
Figure 27. Germany Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Stem Cell Therapy Market Share by Region (2020-2031)
Figure 35. China Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Stem Cell Therapy Market Share by Country (2020-2031)
Figure 43. Mexico Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Stem Cell Therapy Market Share by Country (2020-2031)
Figure 47. Israel Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Medipost Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 51. Theracell Advanced Biotechnology Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 52. Nature Cell Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 53. Stempeutics Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 54. Regeneus Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 55. Bluebird bio, Inc Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 56. NIPRO Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 57. Kyowa Kirin Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 58. CorestemChemon Inc. Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 59. ANTEROGEN.CO., LTD. Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 60. Holostem Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 61. NuVasive Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 62. JCR Pharmaceutical Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 63. Pharmicell Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 64. Medi-post Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 65. Anterogen Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 66. Takeda (TiGenix) Revenue Growth Rate in Stem Cell Therapy Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 19.7% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Stem Cell Therapy in 2025?
Which companies rank high in the global Stem Cell Therapy market?
What is the annual compound growth rate of the global Stem Cell Therapy market size from 2025 to 2031?
What was the global market size of Stem Cell Therapy in 2031?
Related Reports
Global Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Stem Cell Therapy market size was US$ 807 million in 2025 and is forecast to reach a readjusted size of US$ 2793 million by 2032 with a CAGR of 19.7% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 105
USD 4250.00
(Single User License)
Global Stem Cell Therapy Market Research Report 2026
The global Stem Cell Therapy market was valued at US$ 807 million in 2025 and is anticipated to reach US$ 2793 million by 2032, at a CAGR of 19.7% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 139
USD 2900.00
(Single User License)
Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Stem Cell Therapy was estimated to be worth US$ 807 million in 2025 and is projected to reach US$ 2793 million, growing at a CAGR of 19.7% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 131
USD 3950.00
(Single User License)
Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published Date: 2025-10-16
Pages: 123
USD 3950.00
(Single User License)
Global Stem Cell Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Stem Cell Therapy market is projected to grow from US$ 685 million in 2024 to US$ 2373 million by 2031, at a CAGR of 19.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 149
USD 4900.00
(Single User License)
Global Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Stem Cell Therapy market size was US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published Date: 2025-09-08
Pages: 110
USD 4250.00
(Single User License)
Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Stem Cell Therapy was estimated to be worth US$ 685 million and is forecast to reach approximately US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 130
USD 5900.00
(Single User License)
Stem Cell Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 93
USD 3950.00
(Single User License)
Global Stem Cell Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Published Date: 2024-04-17
Pages: 140
USD 5600.00
(Single User License)
Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Published Date: 2024-04-16
Pages: 122
USD 5900.00
(Single User License)
Global Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Stem Cell Therapy market size was US$ 807 million in 2025 and is forecast to reach a readjusted size of US$ 2793 million by 2032 with a CAGR of 19.7% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 105
USD 4250.00 (Single User License)Global Stem Cell Therapy Market Research Report 2026
The global Stem Cell Therapy market was valued at US$ 807 million in 2025 and is anticipated to reach US$ 2793 million by 2032, at a CAGR of 19.7% from 2026 to 2032.
Published: 2026-01-04
Pages: 139
USD 2900.00 (Single User License)Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Stem Cell Therapy was estimated to be worth US$ 807 million in 2025 and is projected to reach US$ 2793 million, growing at a CAGR of 19.7% from 2026 to 2032.
Published: 2026-01-04
Pages: 131
USD 3950.00 (Single User License)Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published: 2025-10-16
Pages: 123
USD 3950.00 (Single User License)Global Stem Cell Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Stem Cell Therapy market is projected to grow from US$ 685 million in 2024 to US$ 2373 million by 2031, at a CAGR of 19.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 149
USD 4900.00 (Single User License)Global Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Stem Cell Therapy market size was US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published: 2025-09-08
Pages: 110
USD 4250.00 (Single User License)Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Stem Cell Therapy was estimated to be worth US$ 685 million and is forecast to reach approximately US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 130
USD 5900.00 (Single User License)Stem Cell Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 93
USD 3950.00 (Single User License)Global Stem Cell Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Published: 2024-04-17
Pages: 140
USD 5600.00 (Single User License)Global Stem Cell Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Published: 2024-04-16
Pages: 122
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now